USA - NASDAQ:FEMY - US31447E1055 - Common Stock
Overall FEMY gets a fundamental rating of 2 out of 10. We evaluated FEMY against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. FEMY is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -150.14% | ||
| ROE | -1392.05% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.09% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.89 | ||
| Quick Ratio | 0.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.7963
-0.1 (-11.28%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 18.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 17.12 | ||
| P/tB | 17.65 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -150.14% | ||
| ROE | -1392.05% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.09% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 217.58% | ||
| Cap/Sales | 39.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.89 | ||
| Quick Ratio | 0.41 | ||
| Altman-Z | -16.16 |
ChartMill assigns a fundamental rating of 2 / 10 to FEMY.
ChartMill assigns a valuation rating of 0 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.
FEMASYS INC (FEMY) has a profitability rating of 1 / 10.
The financial health rating of FEMASYS INC (FEMY) is 0 / 10.
The Earnings per Share (EPS) of FEMASYS INC (FEMY) is expected to grow by 29.2% in the next year.